The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT01634984 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2015-12-22
Summary
Selected 400 cases of women with primary breast cancer who were treated with operation randomly, then detect the expression of CDK5RAP2 of cancer tissue. At the same time randomly selected 100 women with primary breast cancer who were under neoadjuvant chemotherapy. Detect the expression of CDK5RAP2 before and after neoadjuvant chemotherapy.
Conditions
Sponsors & Collaborators
-
Tianjin Medical University Cancer Institute and Hospital
lead OTHER
Principal Investigators
-
Jin Zhang, Pro. · Tianjin Cancer Hospital
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2016-11-30
- Completion
- 2016-12-31
Countries
- China
Study Locations
More Related Trials
-
Breast Tissue Study of Breast Diseases Among Women in Hong Kong
NCT01885039 ·Status: COMPLETED
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
NCT02530008 ·Status: ACTIVE_NOT_RECRUITING
-
RANKL Inhibition and Breast Tissue Biomarkers
NCT03629717 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED
-
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295 ·Status: RECRUITING
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Quality of Sexual Function in BRCA Mutated Women
NCT05456919 ·Status: UNKNOWN
-
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NCT04960839 ·Status: RECRUITING ·Phase: NA
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Biomarker Study of Breast Tumors
NCT00941408 ·Status: UNKNOWN
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
NCT01668914 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05079074 ·Status: COMPLETED
-
Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients
NCT05901025 ·Status: NOT_YET_RECRUITING
-
The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
NCT06977412 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
BRCA and NACT in TNBC Patients
NCT05750719 ·Status: COMPLETED
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Towards Early Detection of Breast Cancer in High Risk Population
NCT05268913 ·Status: UNKNOWN
-
The Treatment Situation of Chinese County Population With Breast Cancer
NCT05544123 ·Status: UNKNOWN
-
Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI
NCT06663228 ·Status: RECRUITING
-
Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
NCT01227733 ·Status: UNKNOWN
-
Triple Negative Breast Cancer Biomarker Study
NCT01111175 ·Status: COMPLETED
-
Comparison of the Breast Tumor Microenvironment
NCT03165487 ·Status: ACTIVE_NOT_RECRUITING